nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—Toremifene—breast cancer	0.252	1	CrCtD
Tamoxifen—ESRRA—breast cancer	0.073	0.347	CbGaD
Tamoxifen—SULT1A1—breast cancer	0.0553	0.263	CbGaD
Tamoxifen—ESRRA—Fulvestrant—breast cancer	0.0432	0.182	CbGbCtD
Tamoxifen—Bedaquiline—Toremifene—breast cancer	0.0269	0.163	CrCrCtD
Tamoxifen—Clomifene—Toremifene—breast cancer	0.0245	0.148	CrCrCtD
Tamoxifen—Ospemifene—Toremifene—breast cancer	0.0245	0.148	CrCrCtD
Tamoxifen—ESR2—breast cancer	0.0156	0.074	CbGaD
Tamoxifen—CYP1B1—breast cancer	0.0142	0.0675	CbGaD
Tamoxifen—Naftifine—Toremifene—breast cancer	0.0135	0.0815	CrCrCtD
Tamoxifen—DHCR7—Epirubicin—breast cancer	0.0134	0.0563	CbGbCtD
Tamoxifen—ESR2—Fulvestrant—breast cancer	0.0134	0.0562	CbGbCtD
Tamoxifen—EBP—Raloxifene—breast cancer	0.0117	0.0493	CbGbCtD
Tamoxifen—Loperamide—Toremifene—breast cancer	0.0108	0.0654	CrCrCtD
Tamoxifen—CYP19A1—breast cancer	0.0104	0.0496	CbGaD
Tamoxifen—ABCG2—breast cancer	0.00979	0.0466	CbGaD
Tamoxifen—ESR1—breast cancer	0.00959	0.0456	CbGaD
Tamoxifen—Doxylamine—Toremifene—breast cancer	0.00935	0.0566	CrCrCtD
Tamoxifen—Dextropropoxyphene—Toremifene—breast cancer	0.00888	0.0537	CrCrCtD
Tamoxifen—Phenoxybenzamine—Toremifene—breast cancer	0.00888	0.0537	CrCrCtD
Tamoxifen—CYP19A1—Exemestane—breast cancer	0.00862	0.0362	CbGbCtD
Tamoxifen—ESR2—Raloxifene—breast cancer	0.00795	0.0334	CbGbCtD
Tamoxifen—Bromodiphenhydramine—Toremifene—breast cancer	0.0079	0.0478	CrCrCtD
Tamoxifen—CYP1A1—breast cancer	0.00767	0.0365	CbGaD
Tamoxifen—ESR1—Toremifene—breast cancer	0.00737	0.031	CbGbCtD
Tamoxifen—ESR1—Fluoxymesterone—breast cancer	0.00737	0.031	CbGbCtD
Tamoxifen—CYP19A1—Letrozole—breast cancer	0.00733	0.0308	CbGbCtD
Tamoxifen—DHCR7—Doxorubicin—breast cancer	0.00712	0.0299	CbGbCtD
Tamoxifen—ESR1—Fulvestrant—breast cancer	0.00685	0.0288	CbGbCtD
Tamoxifen—CYP19A1—Anastrozole—breast cancer	0.00653	0.0274	CbGbCtD
Tamoxifen—Clofedanol—Toremifene—breast cancer	0.00642	0.0388	CrCrCtD
Tamoxifen—Orphenadrine—Toremifene—breast cancer	0.00621	0.0376	CrCrCtD
Tamoxifen—Benzphetamine—Toremifene—breast cancer	0.00621	0.0376	CrCrCtD
Tamoxifen—CES1—Capecitabine—breast cancer	0.00582	0.0245	CbGbCtD
Tamoxifen—Benzyl Benzoate—Toremifene—breast cancer	0.00575	0.0348	CrCrCtD
Tamoxifen—CYP2D6—breast cancer	0.0057	0.0271	CbGaD
Tamoxifen—Diphenhydramine—Toremifene—breast cancer	0.00552	0.0334	CrCrCtD
Tamoxifen—SIGMAR1—Raloxifene—breast cancer	0.00504	0.0212	CbGbCtD
Tamoxifen—CYP3A4—breast cancer	0.00489	0.0233	CbGaD
Tamoxifen—CYP2A6—Letrozole—breast cancer	0.00464	0.0195	CbGbCtD
Tamoxifen—ABCB1—breast cancer	0.00407	0.0194	CbGaD
Tamoxifen—ESR1—Raloxifene—breast cancer	0.00407	0.0171	CbGbCtD
Tamoxifen—CES1—Irinotecan—breast cancer	0.0036	0.0151	CbGbCtD
Tamoxifen—CYP19A1—Raloxifene—breast cancer	0.0033	0.0139	CbGbCtD
Tamoxifen—CYP1A1—Toremifene—breast cancer	0.00323	0.0136	CbGbCtD
Tamoxifen—CYP1B1—Mitoxantrone—breast cancer	0.00262	0.011	CbGbCtD
Tamoxifen—CYP1B1—Paclitaxel—breast cancer	0.00209	0.0088	CbGbCtD
Tamoxifen—ABCB11—Paclitaxel—breast cancer	0.00209	0.0088	CbGbCtD
Tamoxifen—CYP2B6—Thiotepa—breast cancer	0.00204	0.00858	CbGbCtD
Tamoxifen—ABCB11—Vinblastine—breast cancer	0.00184	0.00772	CbGbCtD
Tamoxifen—CYP19A1—Paclitaxel—breast cancer	0.0017	0.00714	CbGbCtD
Tamoxifen—CYP1A2—Anastrozole—breast cancer	0.00158	0.00664	CbGbCtD
Tamoxifen—CYP1B1—Docetaxel—breast cancer	0.00151	0.00637	CbGbCtD
Tamoxifen—CYP1A2—Toremifene—breast cancer	0.00144	0.00607	CbGbCtD
Tamoxifen—CYP2C9—Anastrozole—breast cancer	0.00142	0.00598	CbGbCtD
Tamoxifen—CYP3A5—Lapatinib—breast cancer	0.00142	0.00595	CbGbCtD
Tamoxifen—CYP2B6—Raloxifene—breast cancer	0.00136	0.00572	CbGbCtD
Tamoxifen—CYP2C8—Lapatinib—breast cancer	0.00136	0.00572	CbGbCtD
Tamoxifen—ABCB1—Toremifene—breast cancer	0.00126	0.00531	CbGbCtD
Tamoxifen—ABCG2—Mitoxantrone—breast cancer	0.00125	0.00524	CbGbCtD
Tamoxifen—CYP19A1—corpus luteum—breast cancer	0.00122	0.0602	CbGeAlD
Tamoxifen—CYP2C19—Lapatinib—breast cancer	0.00114	0.0048	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—breast cancer	0.00113	0.00475	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—breast cancer	0.00113	0.00475	CbGbCtD
Tamoxifen—ABCC2—Paclitaxel—breast cancer	0.0011	0.00463	CbGbCtD
Tamoxifen—CYP3A4—Exemestane—breast cancer	0.00109	0.00459	CbGbCtD
Tamoxifen—ABCC2—Irinotecan—breast cancer	0.00109	0.00457	CbGbCtD
Tamoxifen—CYP2C9—Idarubicin—breast cancer	0.00108	0.00453	CbGbCtD
Tamoxifen—ABCC2—Carboplatin—breast cancer	0.00104	0.00436	CbGbCtD
Tamoxifen—CYP2C8—Raloxifene—breast cancer	0.00103	0.00434	CbGbCtD
Tamoxifen—CYP2A6—Fluorouracil—breast cancer	0.00102	0.00428	CbGbCtD
Tamoxifen—ABCG2—Paclitaxel—breast cancer	0.000996	0.00419	CbGbCtD
Tamoxifen—CYP2D6—Idarubicin—breast cancer	0.000986	0.00414	CbGbCtD
Tamoxifen—ABCG2—Irinotecan—breast cancer	0.000982	0.00413	CbGbCtD
Tamoxifen—ABCC2—Vinblastine—breast cancer	0.000966	0.00406	CbGbCtD
Tamoxifen—ABCG2—Fluorouracil—breast cancer	0.000943	0.00396	CbGbCtD
Tamoxifen—ABCG2—Carboplatin—breast cancer	0.000937	0.00394	CbGbCtD
Tamoxifen—CYP3A4—Letrozole—breast cancer	0.000928	0.0039	CbGbCtD
Tamoxifen—ABCB1—Lapatinib—breast cancer	0.000921	0.00387	CbGbCtD
Tamoxifen—CYP2E1—Mitoxantrone—breast cancer	0.00089	0.00374	CbGbCtD
Tamoxifen—CYP3A4—Anastrozole—breast cancer	0.000827	0.00348	CbGbCtD
Tamoxifen—ABCC2—Docetaxel—breast cancer	0.000796	0.00335	CbGbCtD
Tamoxifen—CYP3A4—Toremifene—breast cancer	0.000757	0.00318	CbGbCtD
Tamoxifen—CYP3A7—Paclitaxel—breast cancer	0.000735	0.00309	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.000735	0.00309	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.000725	0.00305	CbGbCtD
Tamoxifen—CYP3A7—Irinotecan—breast cancer	0.000725	0.00305	CbGbCtD
Tamoxifen—ABCG2—Docetaxel—breast cancer	0.00072	0.00303	CbGbCtD
Tamoxifen—CYP3A4—Fulvestrant—breast cancer	0.000703	0.00296	CbGbCtD
Tamoxifen—CYP2B6—Irinotecan—breast cancer	0.000691	0.0029	CbGbCtD
Tamoxifen—CYP3A4—Thiotepa—breast cancer	0.000627	0.00264	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—breast cancer	0.000594	0.0025	CbGbCtD
Tamoxifen—CYP2C9—Capecitabine—breast cancer	0.000591	0.00248	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—breast cancer	0.000575	0.00242	CbGbCtD
Tamoxifen—CYP3A4—Ixabepilone—breast cancer	0.000573	0.00241	CbGbCtD
Tamoxifen—CYP3A4—Lapatinib—breast cancer	0.000552	0.00232	CbGbCtD
Tamoxifen—CYP3A5—Paclitaxel—breast cancer	0.000552	0.00232	CbGbCtD
Tamoxifen—CYP3A5—Irinotecan—breast cancer	0.000544	0.00229	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—breast cancer	0.000537	0.00226	CbGbCtD
Tamoxifen—CYP3A7—Docetaxel—breast cancer	0.000532	0.00224	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.000532	0.00224	CbGbCtD
Tamoxifen—CYP2C8—Paclitaxel—breast cancer	0.00053	0.00223	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—breast cancer	0.00052	0.00219	CbGbCtD
Tamoxifen—ABCB1—Vinorelbine—breast cancer	0.000511	0.00215	CbGbCtD
Tamoxifen—CYP2C8—Fluorouracil—breast cancer	0.000502	0.00211	CbGbCtD
Tamoxifen—CYP2D6—Vinorelbine—breast cancer	0.000481	0.00202	CbGbCtD
Tamoxifen—ABCB1—Mitoxantrone—breast cancer	0.00045	0.00189	CbGbCtD
Tamoxifen—CYP3A4—Raloxifene—breast cancer	0.000418	0.00176	CbGbCtD
Tamoxifen—DHCR7—mammary gland—breast cancer	0.000406	0.02	CbGeAlD
Tamoxifen—FMO1—mammary gland—breast cancer	0.000406	0.02	CbGeAlD
Tamoxifen—EBPL—epithelium—breast cancer	0.0004	0.0197	CbGeAlD
Tamoxifen—CYP3A5—Docetaxel—breast cancer	0.000399	0.00168	CbGbCtD
Tamoxifen—ABCB1—Gemcitabine—breast cancer	0.000397	0.00167	CbGbCtD
Tamoxifen—CYP1A2—Fluorouracil—breast cancer	0.000389	0.00163	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—breast cancer	0.000377	0.00159	CbGbCtD
Tamoxifen—CYP2C9—Paclitaxel—breast cancer	0.00037	0.00156	CbGbCtD
Tamoxifen—ABCB1—Paclitaxel—breast cancer	0.000359	0.00151	CbGbCtD
Tamoxifen—ABCB1—Irinotecan—breast cancer	0.000354	0.00149	CbGbCtD
Tamoxifen—CYP2C9—Fluorouracil—breast cancer	0.00035	0.00147	CbGbCtD
Tamoxifen—DHCR7—nipple—breast cancer	0.000335	0.0166	CbGeAlD
Tamoxifen—ESRRA—nipple—breast cancer	0.00033	0.0163	CbGeAlD
Tamoxifen—EBPL—adipose tissue—breast cancer	0.000323	0.0159	CbGeAlD
Tamoxifen—EBP—uterus—breast cancer	0.000317	0.0156	CbGeAlD
Tamoxifen—ABCB1—Vinblastine—breast cancer	0.000315	0.00132	CbGbCtD
Tamoxifen—CYP3A4—Vinorelbine—breast cancer	0.000306	0.00129	CbGbCtD
Tamoxifen—CYP2D6—Vinblastine—breast cancer	0.000297	0.00125	CbGbCtD
Tamoxifen—EBPL—adrenal gland—breast cancer	0.00029	0.0143	CbGeAlD
Tamoxifen—EBP—female reproductive system—breast cancer	0.000285	0.0141	CbGeAlD
Tamoxifen—EBPL—female gonad—breast cancer	0.00027	0.0133	CbGeAlD
Tamoxifen—CYP3A4—Mitoxantrone—breast cancer	0.00027	0.00113	CbGbCtD
Tamoxifen—ABCB1—Docetaxel—breast cancer	0.00026	0.00109	CbGbCtD
Tamoxifen—SULT1A1—pituitary gland—breast cancer	0.000258	0.0127	CbGeAlD
Tamoxifen—SULT1A1—adipose tissue—breast cancer	0.000257	0.0127	CbGeAlD
Tamoxifen—EBPL—endocrine gland—breast cancer	0.000251	0.0124	CbGeAlD
Tamoxifen—EBP—endocrine gland—breast cancer	0.000241	0.0119	CbGeAlD
Tamoxifen—ESR2—mammary gland—breast cancer	0.00024	0.0118	CbGeAlD
Tamoxifen—SULT1A1—female reproductive system—breast cancer	0.000236	0.0116	CbGeAlD
Tamoxifen—SULT1A1—adrenal gland—breast cancer	0.00023	0.0114	CbGeAlD
Tamoxifen—CYP3A4—Paclitaxel—breast cancer	0.000215	0.000904	CbGbCtD
Tamoxifen—DHCR7—skin of body—breast cancer	0.000215	0.0106	CbGeAlD
Tamoxifen—SULT1A1—female gonad—breast cancer	0.000215	0.0106	CbGeAlD
Tamoxifen—CYP3A4—Irinotecan—breast cancer	0.000212	0.000892	CbGbCtD
Tamoxifen—FMO1—endometrium—breast cancer	0.000203	0.01	CbGeAlD
Tamoxifen—SULT1A1—endocrine gland—breast cancer	0.0002	0.00985	CbGeAlD
Tamoxifen—ESRRA—endometrium—breast cancer	0.000199	0.00984	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—breast cancer	0.000193	0.000813	CbGbCtD
Tamoxifen—CYP3A4—Vinblastine—breast cancer	0.000189	0.000793	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—breast cancer	0.000187	0.000788	CbGbCtD
Tamoxifen—SIGMAR1—mammary gland—breast cancer	0.000186	0.00916	CbGeAlD
Tamoxifen—ESRRA—uterus—breast cancer	0.000184	0.00907	CbGeAlD
Tamoxifen—FMO1—pituitary gland—breast cancer	0.000183	0.00905	CbGeAlD
Tamoxifen—DHCR7—pituitary gland—breast cancer	0.000183	0.00905	CbGeAlD
Tamoxifen—DHCR7—adipose tissue—breast cancer	0.000183	0.00901	CbGeAlD
Tamoxifen—FMO1—adipose tissue—breast cancer	0.000183	0.00901	CbGeAlD
Tamoxifen—CYP2D6—Doxorubicin—breast cancer	0.000182	0.000766	CbGbCtD
Tamoxifen—ESRRA—pituitary gland—breast cancer	0.00018	0.00891	CbGeAlD
Tamoxifen—ESRRA—adipose tissue—breast cancer	0.00018	0.00887	CbGeAlD
Tamoxifen—CYP1B1—mammary gland—breast cancer	0.000177	0.00871	CbGeAlD
Tamoxifen—UGT1A4—endocrine gland—breast cancer	0.000174	0.0086	CbGeAlD
Tamoxifen—EBPL—lymph node—breast cancer	0.000174	0.00857	CbGeAlD
Tamoxifen—DHCR7—female reproductive system—breast cancer	0.000168	0.00828	CbGeAlD
Tamoxifen—ESRRA—female reproductive system—breast cancer	0.000165	0.00815	CbGeAlD
Tamoxifen—ESR1—mammary gland—breast cancer	0.000164	0.0081	CbGeAlD
Tamoxifen—DHCR7—adrenal gland—breast cancer	0.000164	0.00808	CbGeAlD
Tamoxifen—FMO1—adrenal gland—breast cancer	0.000164	0.00808	CbGeAlD
Tamoxifen—ESRRA—adrenal gland—breast cancer	0.000161	0.00796	CbGeAlD
Tamoxifen—FMO3—pituitary gland—breast cancer	0.000158	0.00782	CbGeAlD
Tamoxifen—DHCR7—bone marrow—breast cancer	0.000158	0.00782	CbGeAlD
Tamoxifen—FMO3—adipose tissue—breast cancer	0.000158	0.00779	CbGeAlD
Tamoxifen—ESRRA—bone marrow—breast cancer	0.000156	0.0077	CbGeAlD
Tamoxifen—CYP3A4—Docetaxel—breast cancer	0.000156	0.000654	CbGbCtD
Tamoxifen—SIGMAR1—nipple—breast cancer	0.000154	0.00758	CbGeAlD
Tamoxifen—DHCR7—female gonad—breast cancer	0.000153	0.00754	CbGeAlD
Tamoxifen—FMO1—female gonad—breast cancer	0.000153	0.00754	CbGeAlD
Tamoxifen—ESRRA—female gonad—breast cancer	0.00015	0.00742	CbGeAlD
Tamoxifen—DHCR7—endocrine gland—breast cancer	0.000142	0.00701	CbGeAlD
Tamoxifen—FMO1—endocrine gland—breast cancer	0.000142	0.00701	CbGeAlD
Tamoxifen—FMO3—adrenal gland—breast cancer	0.000142	0.00698	CbGeAlD
Tamoxifen—ESRRA—endocrine gland—breast cancer	0.00014	0.0069	CbGeAlD
Tamoxifen—SULT1A1—lymph node—breast cancer	0.000138	0.00681	CbGeAlD
Tamoxifen—CYP2C8—mammary gland—breast cancer	0.000135	0.00667	CbGeAlD
Tamoxifen—ESR2—epithelium—breast cancer	0.000133	0.00659	CbGeAlD
Tamoxifen—EBP—Azacitidine—Gemcitabine—breast cancer	0.000127	1	CbGdCrCtD
Tamoxifen—CES1—adipose tissue—breast cancer	0.000125	0.00615	CbGeAlD
Tamoxifen—ABCB11—endocrine gland—breast cancer	0.000124	0.00613	CbGeAlD
Tamoxifen—FMO3—endocrine gland—breast cancer	0.000123	0.00606	CbGeAlD
Tamoxifen—CYP3A7—endocrine gland—breast cancer	0.000121	0.00599	CbGeAlD
Tamoxifen—CYP2C9—mammary gland—breast cancer	0.00012	0.00593	CbGeAlD
Tamoxifen—ESR2—endometrium—breast cancer	0.00012	0.00591	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—breast cancer	0.000116	0.000487	CbGbCtD
Tamoxifen—CES1—female reproductive system—breast cancer	0.000114	0.00565	CbGeAlD
Tamoxifen—ESR1—embryo—breast cancer	0.000112	0.00553	CbGeAlD
Tamoxifen—CES1—adrenal gland—breast cancer	0.000112	0.00551	CbGeAlD
Tamoxifen—ESR2—uterus—breast cancer	0.00011	0.00544	CbGeAlD
Tamoxifen—CYP2A6—adipose tissue—breast cancer	0.000108	0.00535	CbGeAlD
Tamoxifen—ESR2—pituitary gland—breast cancer	0.000108	0.00535	CbGeAlD
Tamoxifen—CYP1A2—nipple—breast cancer	0.000105	0.00516	CbGeAlD
Tamoxifen—CES1—female gonad—breast cancer	0.000104	0.00514	CbGeAlD
Tamoxifen—CYP1A1—nipple—breast cancer	0.000103	0.00509	CbGeAlD
Tamoxifen—Dimetacrine—ACHE—breast cancer	0.000101	0.0863	CrCbGaD
Tamoxifen—ESR2—female reproductive system—breast cancer	9.91e-05	0.00489	CbGeAlD
Tamoxifen—DHCR7—lymph node—breast cancer	9.82e-05	0.00484	CbGeAlD
Tamoxifen—FMO1—lymph node—breast cancer	9.82e-05	0.00484	CbGeAlD
Tamoxifen—CES1—endocrine gland—breast cancer	9.69e-05	0.00478	CbGeAlD
Tamoxifen—ESR2—adrenal gland—breast cancer	9.67e-05	0.00478	CbGeAlD
Tamoxifen—ESRRA—lymph node—breast cancer	9.66e-05	0.00477	CbGeAlD
Tamoxifen—CYP19A1—endometrium—breast cancer	9.43e-05	0.00465	CbGeAlD
Tamoxifen—CYP1B1—skin of body—breast cancer	9.35e-05	0.00462	CbGeAlD
Tamoxifen—SIGMAR1—endometrium—breast cancer	9.27e-05	0.00458	CbGeAlD
Tamoxifen—ESR1—epithelium—breast cancer	9.14e-05	0.00451	CbGeAlD
Tamoxifen—Diethylstilbestrol—COMT—breast cancer	9.04e-05	0.0774	CrCbGaD
Tamoxifen—ESR2—female gonad—breast cancer	9.02e-05	0.00445	CbGeAlD
Tamoxifen—CYP19A1—uterus—breast cancer	8.69e-05	0.00429	CbGeAlD
Tamoxifen—SIGMAR1—uterus—breast cancer	8.54e-05	0.00422	CbGeAlD
Tamoxifen—CYP19A1—adipose tissue—breast cancer	8.5e-05	0.0042	CbGeAlD
Tamoxifen—FMO3—lymph node—breast cancer	8.48e-05	0.00419	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR2—breast cancer	8.43e-05	0.0722	CrCbGaD
Tamoxifen—SIGMAR1—pituitary gland—breast cancer	8.39e-05	0.00414	CbGeAlD
Tamoxifen—ESR2—endocrine gland—breast cancer	8.39e-05	0.00414	CbGeAlD
Tamoxifen—SIGMAR1—adipose tissue—breast cancer	8.36e-05	0.00412	CbGeAlD
Tamoxifen—ESR1—endometrium—breast cancer	8.2e-05	0.00405	CbGeAlD
Tamoxifen—CYP1B1—uterus—breast cancer	8.12e-05	0.00401	CbGeAlD
Tamoxifen—CYP1B1—pituitary gland—breast cancer	7.98e-05	0.00394	CbGeAlD
Tamoxifen—CYP1B1—adipose tissue—breast cancer	7.95e-05	0.00392	CbGeAlD
Tamoxifen—CYP19A1—female reproductive system—breast cancer	7.81e-05	0.00386	CbGeAlD
Tamoxifen—CYP19A1—adrenal gland—breast cancer	7.62e-05	0.00376	CbGeAlD
Tamoxifen—ESR1—uterus—breast cancer	7.55e-05	0.00373	CbGeAlD
Tamoxifen—SIGMAR1—adrenal gland—breast cancer	7.5e-05	0.0037	CbGeAlD
Tamoxifen—ABCC2—female reproductive system—breast cancer	7.46e-05	0.00368	CbGeAlD
Tamoxifen—ESR1—pituitary gland—breast cancer	7.42e-05	0.00366	CbGeAlD
Tamoxifen—ESR1—adipose tissue—breast cancer	7.39e-05	0.00365	CbGeAlD
Tamoxifen—CYP1B1—female reproductive system—breast cancer	7.3e-05	0.0036	CbGeAlD
Tamoxifen—ABCC2—adrenal gland—breast cancer	7.28e-05	0.00359	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—breast cancer	7.25e-05	0.00358	CbGeAlD
Tamoxifen—CYP1B1—adrenal gland—breast cancer	7.13e-05	0.00352	CbGeAlD
Tamoxifen—CYP19A1—female gonad—breast cancer	7.11e-05	0.00351	CbGeAlD
Tamoxifen—SIGMAR1—female gonad—breast cancer	6.99e-05	0.00345	CbGeAlD
Tamoxifen—CYP1A1—epithelium—breast cancer	6.95e-05	0.00343	CbGeAlD
Tamoxifen—ESR1—female reproductive system—breast cancer	6.79e-05	0.00335	CbGeAlD
Tamoxifen—CYP2C8—endometrium—breast cancer	6.75e-05	0.00333	CbGeAlD
Tamoxifen—CES1—lymph node—breast cancer	6.7e-05	0.00331	CbGeAlD
Tamoxifen—CYP1B1—female gonad—breast cancer	6.65e-05	0.00328	CbGeAlD
Tamoxifen—ESR1—adrenal gland—breast cancer	6.63e-05	0.00327	CbGeAlD
Tamoxifen—CYP19A1—endocrine gland—breast cancer	6.61e-05	0.00326	CbGeAlD
Tamoxifen—CYP1A1—skin of body—breast cancer	6.61e-05	0.00326	CbGeAlD
Tamoxifen—ABCG2—endometrium—breast cancer	6.57e-05	0.00324	CbGeAlD
Tamoxifen—CYP2B6—skin of body—breast cancer	6.42e-05	0.00317	CbGeAlD
Tamoxifen—ABCC2—endocrine gland—breast cancer	6.31e-05	0.00311	CbGeAlD
Tamoxifen—CYP1B1—endocrine gland—breast cancer	6.18e-05	0.00305	CbGeAlD
Tamoxifen—ESR1—female gonad—breast cancer	6.18e-05	0.00305	CbGeAlD
Tamoxifen—CYP2C8—pituitary gland—breast cancer	6.11e-05	0.00302	CbGeAlD
Tamoxifen—ABCG2—uterus—breast cancer	6.05e-05	0.00299	CbGeAlD
Tamoxifen—ABCG2—pituitary gland—breast cancer	5.94e-05	0.00293	CbGeAlD
Tamoxifen—ABCG2—adipose tissue—breast cancer	5.92e-05	0.00292	CbGeAlD
Tamoxifen—ESR2—lymph node—breast cancer	5.8e-05	0.00286	CbGeAlD
Tamoxifen—ESR1—endocrine gland—breast cancer	5.75e-05	0.00284	CbGeAlD
Tamoxifen—CYP1A1—uterus—breast cancer	5.74e-05	0.00283	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP19A1—breast cancer	5.64e-05	0.0483	CrCbGaD
Tamoxifen—CYP1A1—adipose tissue—breast cancer	5.62e-05	0.00277	CbGeAlD
Tamoxifen—CYP2C8—female reproductive system—breast cancer	5.59e-05	0.00276	CbGeAlD
Tamoxifen—CYP3A5—adipose tissue—breast cancer	5.49e-05	0.00271	CbGeAlD
Tamoxifen—CYP2C19—endocrine gland—breast cancer	5.42e-05	0.00268	CbGeAlD
Tamoxifen—ABCG2—adrenal gland—breast cancer	5.31e-05	0.00262	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCG2—breast cancer	5.3e-05	0.0454	CrCbGaD
Tamoxifen—Diethylstilbestrol—ESR1—breast cancer	5.19e-05	0.0445	CrCbGaD
Tamoxifen—CYP1A1—female reproductive system—breast cancer	5.16e-05	0.00255	CbGeAlD
Tamoxifen—Bedaquiline—CYP3A4—breast cancer	5.15e-05	0.0441	CrCbGaD
Tamoxifen—ABCG2—bone marrow—breast cancer	5.13e-05	0.00253	CbGeAlD
Tamoxifen—Ospemifene—ESR1—breast cancer	5.05e-05	0.0433	CrCbGaD
Tamoxifen—CYP2B6—female reproductive system—breast cancer	5.02e-05	0.00248	CbGeAlD
Tamoxifen—CYP2C9—female reproductive system—breast cancer	4.97e-05	0.00245	CbGeAlD
Tamoxifen—ABCG2—female gonad—breast cancer	4.95e-05	0.00244	CbGeAlD
Tamoxifen—CYP2B6—adrenal gland—breast cancer	4.9e-05	0.00242	CbGeAlD
Tamoxifen—CYP2C8—endocrine gland—breast cancer	4.73e-05	0.00234	CbGeAlD
Tamoxifen—CYP2E1—female reproductive system—breast cancer	4.71e-05	0.00232	CbGeAlD
Tamoxifen—CYP1A1—female gonad—breast cancer	4.7e-05	0.00232	CbGeAlD
Tamoxifen—CYP2E1—adrenal gland—breast cancer	4.59e-05	0.00227	CbGeAlD
Tamoxifen—CYP3A5—female gonad—breast cancer	4.59e-05	0.00227	CbGeAlD
Tamoxifen—CYP19A1—lymph node—breast cancer	4.57e-05	0.00226	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—breast cancer	4.49e-05	0.00222	CbGeAlD
Tamoxifen—CYP1A2—endocrine gland—breast cancer	4.43e-05	0.00219	CbGeAlD
Tamoxifen—ABCB1—embryo—breast cancer	4.42e-05	0.00218	CbGeAlD
Tamoxifen—CYP1A1—endocrine gland—breast cancer	4.37e-05	0.00216	CbGeAlD
Tamoxifen—ABCC2—lymph node—breast cancer	4.36e-05	0.00215	CbGeAlD
Tamoxifen—CYP1B1—lymph node—breast cancer	4.27e-05	0.00211	CbGeAlD
Tamoxifen—CYP3A5—endocrine gland—breast cancer	4.27e-05	0.00211	CbGeAlD
Tamoxifen—CYP2B6—endocrine gland—breast cancer	4.25e-05	0.0021	CbGeAlD
Tamoxifen—CYP2C9—endocrine gland—breast cancer	4.2e-05	0.00208	CbGeAlD
Tamoxifen—Toremifene—ESR1—breast cancer	4.12e-05	0.0353	CrCbGaD
Tamoxifen—CYP2E1—endocrine gland—breast cancer	3.98e-05	0.00197	CbGeAlD
Tamoxifen—ESR1—lymph node—breast cancer	3.97e-05	0.00196	CbGeAlD
Tamoxifen—Clomifene—CYP19A1—breast cancer	3.87e-05	0.0331	CrCbGaD
Tamoxifen—CYP3A4—female reproductive system—breast cancer	3.79e-05	0.00187	CbGeAlD
Tamoxifen—CYP2D6—female reproductive system—breast cancer	3.73e-05	0.00184	CbGeAlD
Tamoxifen—ABCB1—epithelium—breast cancer	3.61e-05	0.00178	CbGeAlD
Tamoxifen—Clomifene—ESR1—breast cancer	3.56e-05	0.0305	CrCbGaD
Tamoxifen—CYP2D6—female gonad—breast cancer	3.39e-05	0.00167	CbGeAlD
Tamoxifen—Toremifene—CYP1A1—breast cancer	3.29e-05	0.0282	CrCbGaD
Tamoxifen—ABCB1—endometrium—breast cancer	3.24e-05	0.0016	CbGeAlD
Tamoxifen—CYP3A4—endocrine gland—breast cancer	3.21e-05	0.00158	CbGeAlD
Tamoxifen—ABCG2—lymph node—breast cancer	3.18e-05	0.00157	CbGeAlD
Tamoxifen—CYP2D6—endocrine gland—breast cancer	3.15e-05	0.00156	CbGeAlD
Tamoxifen—Orphenadrine—SCN10A—breast cancer	3.09e-05	0.0265	CrCbGaD
Tamoxifen—Levomethadyl Acetate—CYP19A1—breast cancer	3.02e-05	0.0259	CrCbGaD
Tamoxifen—CYP1A1—lymph node—breast cancer	3.02e-05	0.00149	CbGeAlD
Tamoxifen—ABCB1—uterus—breast cancer	2.98e-05	0.00147	CbGeAlD
Tamoxifen—ABCB1—pituitary gland—breast cancer	2.93e-05	0.00145	CbGeAlD
Tamoxifen—ABCB1—adipose tissue—breast cancer	2.92e-05	0.00144	CbGeAlD
Tamoxifen—Clomifene—CYP1A1—breast cancer	2.85e-05	0.0244	CrCbGaD
Tamoxifen—ABCB1—female reproductive system—breast cancer	2.68e-05	0.00132	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP3A4—breast cancer	2.65e-05	0.0227	CrCbGaD
Tamoxifen—ABCB1—adrenal gland—breast cancer	2.62e-05	0.00129	CbGeAlD
Tamoxifen—Ospemifene—CYP3A4—breast cancer	2.58e-05	0.0221	CrCbGaD
Tamoxifen—Tripelennamine—CYP2D6—breast cancer	2.55e-05	0.0218	CrCbGaD
Tamoxifen—ABCB1—bone marrow—breast cancer	2.53e-05	0.00125	CbGeAlD
Tamoxifen—ABCB1—female gonad—breast cancer	2.44e-05	0.0012	CbGeAlD
Tamoxifen—ABCB1—endocrine gland—breast cancer	2.27e-05	0.00112	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCB1—breast cancer	2.21e-05	0.0189	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP2D6—breast cancer	2.12e-05	0.0181	CrCbGaD
Tamoxifen—Toremifene—CYP3A4—breast cancer	2.1e-05	0.018	CrCbGaD
Tamoxifen—Clomifene—CYP3A4—breast cancer	1.82e-05	0.0156	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP3A4—breast cancer	1.82e-05	0.0156	CrCbGaD
Tamoxifen—Methadone—CYP19A1—breast cancer	1.77e-05	0.0152	CrCbGaD
Tamoxifen—Toremifene—ABCB1—breast cancer	1.75e-05	0.015	CrCbGaD
Tamoxifen—ABCB1—lymph node—breast cancer	1.57e-05	0.000774	CbGeAlD
Tamoxifen—Clomifene—ABCB1—breast cancer	1.51e-05	0.0129	CrCbGaD
Tamoxifen—Diphenhydramine—PTGS1—breast cancer	1.48e-05	0.0126	CrCbGaD
Tamoxifen—Dextropropoxyphene—CYP2D6—breast cancer	1.43e-05	0.0122	CrCbGaD
Tamoxifen—Levomethadyl Acetate—CYP3A4—breast cancer	1.42e-05	0.0122	CrCbGaD
Tamoxifen—Loperamide—CYP2D6—breast cancer	1.36e-05	0.0117	CrCbGaD
Tamoxifen—Dextropropoxyphene—CYP3A4—breast cancer	1.23e-05	0.0105	CrCbGaD
Tamoxifen—Loperamide—CYP3A4—breast cancer	1.17e-05	0.01	CrCbGaD
Tamoxifen—Benzphetamine—CYP3A4—breast cancer	1.08e-05	0.00921	CrCbGaD
Tamoxifen—Phenoxybenzamine—CYP3A4—breast cancer	1.03e-05	0.00881	CrCbGaD
Tamoxifen—Diphenhydramine—CYP2D6—breast cancer	1.01e-05	0.00861	CrCbGaD
Tamoxifen—Loperamide—ABCB1—breast cancer	9.73e-06	0.00833	CrCbGaD
Tamoxifen—Methadone—CYP2D6—breast cancer	9.7e-06	0.00831	CrCbGaD
Tamoxifen—Methadone—CYP3A4—breast cancer	8.32e-06	0.00713	CrCbGaD
Tamoxifen—Orphenadrine—CYP3A4—breast cancer	8.15e-06	0.00698	CrCbGaD
Tamoxifen—Promazine—CYP3A4—breast cancer	7.44e-06	0.00637	CrCbGaD
Tamoxifen—Weight increased—Doxorubicin—breast cancer	7.06e-06	0.000104	CcSEcCtD
Tamoxifen—Discomfort—Capecitabine—breast cancer	7.05e-06	0.000104	CcSEcCtD
Tamoxifen—Pruritus—Gemcitabine—breast cancer	7.05e-06	0.000104	CcSEcCtD
Tamoxifen—Nausea—Thiotepa—breast cancer	7.03e-06	0.000103	CcSEcCtD
Tamoxifen—Infection—Docetaxel—breast cancer	7.02e-06	0.000103	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—breast cancer	7.02e-06	0.000103	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—breast cancer	7.01e-06	0.000103	CcSEcCtD
Tamoxifen—Diarrhoea—Mitoxantrone—breast cancer	6.99e-06	0.000103	CcSEcCtD
Tamoxifen—Diarrhoea—Irinotecan—breast cancer	6.99e-06	0.000103	CcSEcCtD
Tamoxifen—Dry mouth—Capecitabine—breast cancer	6.98e-06	0.000103	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—breast cancer	6.96e-06	0.000102	CcSEcCtD
Tamoxifen—Methadone—ABCB1—breast cancer	6.93e-06	0.00593	CrCbGaD
Tamoxifen—Pruritus—Fluorouracil—breast cancer	6.93e-06	0.000102	CcSEcCtD
Tamoxifen—Thrombocytopenia—Docetaxel—breast cancer	6.92e-06	0.000102	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—breast cancer	6.91e-06	0.000102	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—breast cancer	6.86e-06	0.000101	CcSEcCtD
Tamoxifen—Oedema—Capecitabine—breast cancer	6.84e-06	0.000101	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Paclitaxel—breast cancer	6.82e-06	0.0001	CcSEcCtD
Tamoxifen—Diarrhoea—Gemcitabine—breast cancer	6.81e-06	0.0001	CcSEcCtD
Tamoxifen—Infection—Capecitabine—breast cancer	6.8e-06	9.99e-05	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—breast cancer	6.78e-06	9.96e-05	CcSEcCtD
Tamoxifen—Dizziness—Irinotecan—breast cancer	6.76e-06	9.94e-05	CcSEcCtD
Tamoxifen—Haemoglobin—Epirubicin—breast cancer	6.74e-06	9.91e-05	CcSEcCtD
Tamoxifen—Anorexia—Docetaxel—breast cancer	6.74e-06	9.9e-05	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—breast cancer	6.72e-06	9.88e-05	CcSEcCtD
Tamoxifen—Haemorrhage—Epirubicin—breast cancer	6.71e-06	9.86e-05	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—breast cancer	6.71e-06	9.86e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Fluorouracil—breast cancer	6.7e-06	9.85e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Capecitabine—breast cancer	6.7e-06	9.85e-05	CcSEcCtD
Tamoxifen—Hypoaesthesia—Epirubicin—breast cancer	6.68e-06	9.81e-05	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—breast cancer	6.66e-06	9.79e-05	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—breast cancer	6.63e-06	9.74e-05	CcSEcCtD
Tamoxifen—Urticaria—Paclitaxel—breast cancer	6.62e-06	9.74e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Capecitabine—breast cancer	6.61e-06	9.72e-05	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—breast cancer	6.61e-06	9.72e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Paclitaxel—breast cancer	6.59e-06	9.69e-05	CcSEcCtD
Tamoxifen—Anorexia—Capecitabine—breast cancer	6.52e-06	9.59e-05	CcSEcCtD
Tamoxifen—Vomiting—Irinotecan—breast cancer	6.5e-06	9.55e-05	CcSEcCtD
Tamoxifen—Vomiting—Mitoxantrone—breast cancer	6.5e-06	9.55e-05	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—breast cancer	6.49e-06	9.54e-05	CcSEcCtD
Tamoxifen—Dizziness—Fluorouracil—breast cancer	6.47e-06	9.52e-05	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—breast cancer	6.47e-06	9.5e-05	CcSEcCtD
Tamoxifen—Rash—Irinotecan—breast cancer	6.45e-06	9.47e-05	CcSEcCtD
Tamoxifen—Rash—Mitoxantrone—breast cancer	6.45e-06	9.47e-05	CcSEcCtD
Tamoxifen—Dermatitis—Mitoxantrone—breast cancer	6.44e-06	9.47e-05	CcSEcCtD
Tamoxifen—Dermatitis—Irinotecan—breast cancer	6.44e-06	9.47e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Docetaxel—breast cancer	6.44e-06	9.46e-05	CcSEcCtD
Tamoxifen—Headache—Irinotecan—breast cancer	6.4e-06	9.41e-05	CcSEcCtD
Tamoxifen—Headache—Mitoxantrone—breast cancer	6.4e-06	9.41e-05	CcSEcCtD
Tamoxifen—Insomnia—Docetaxel—breast cancer	6.39e-06	9.4e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Docetaxel—breast cancer	6.35e-06	9.33e-05	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—breast cancer	6.34e-06	9.32e-05	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—breast cancer	6.33e-06	9.31e-05	CcSEcCtD
Tamoxifen—Vomiting—Gemcitabine—breast cancer	6.33e-06	9.31e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Docetaxel—breast cancer	6.3e-06	9.26e-05	CcSEcCtD
Tamoxifen—Rash—Gemcitabine—breast cancer	6.28e-06	9.23e-05	CcSEcCtD
Tamoxifen—Dermatitis—Gemcitabine—breast cancer	6.27e-06	9.22e-05	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—breast cancer	6.24e-06	9.17e-05	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—breast cancer	6.24e-06	9.17e-05	CcSEcCtD
Tamoxifen—Headache—Gemcitabine—breast cancer	6.24e-06	9.17e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Capecitabine—breast cancer	6.23e-06	9.16e-05	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—breast cancer	6.23e-06	9.15e-05	CcSEcCtD
Tamoxifen—Vomiting—Fluorouracil—breast cancer	6.23e-06	9.15e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Docetaxel—breast cancer	6.22e-06	9.14e-05	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—breast cancer	6.21e-06	9.13e-05	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—breast cancer	6.21e-06	9.13e-05	CcSEcCtD
Tamoxifen—Insomnia—Capecitabine—breast cancer	6.19e-06	9.1e-05	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—breast cancer	6.18e-06	9.08e-05	CcSEcCtD
Tamoxifen—Rash—Fluorouracil—breast cancer	6.17e-06	9.07e-05	CcSEcCtD
Tamoxifen—Dermatitis—Fluorouracil—breast cancer	6.17e-06	9.07e-05	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—breast cancer	6.16e-06	9.06e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Capecitabine—breast cancer	6.14e-06	9.03e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Docetaxel—breast cancer	6.14e-06	9.03e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Paclitaxel—breast cancer	6.14e-06	9.03e-05	CcSEcCtD
Tamoxifen—Headache—Fluorouracil—breast cancer	6.13e-06	9.02e-05	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—breast cancer	6.12e-06	8.99e-05	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—breast cancer	6.11e-06	8.98e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Docetaxel—breast cancer	6.1e-06	8.97e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Capecitabine—breast cancer	6.1e-06	8.97e-05	CcSEcCtD
Tamoxifen—Fatigue—Docetaxel—breast cancer	6.09e-06	8.96e-05	CcSEcCtD
Tamoxifen—Nausea—Irinotecan—breast cancer	6.07e-06	8.93e-05	CcSEcCtD
Tamoxifen—Nausea—Mitoxantrone—breast cancer	6.07e-06	8.93e-05	CcSEcCtD
Tamoxifen—Constipation—Docetaxel—breast cancer	6.04e-06	8.88e-05	CcSEcCtD
Tamoxifen—Pain—Docetaxel—breast cancer	6.04e-06	8.88e-05	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—breast cancer	6.04e-06	8.87e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Capecitabine—breast cancer	6.02e-06	8.85e-05	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—breast cancer	5.99e-06	8.81e-05	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—breast cancer	5.98e-06	8.79e-05	CcSEcCtD
Tamoxifen—Asthenia—Paclitaxel—breast cancer	5.98e-06	8.79e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Capecitabine—breast cancer	5.95e-06	8.74e-05	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—breast cancer	5.93e-06	8.71e-05	CcSEcCtD
Tamoxifen—Nausea—Gemcitabine—breast cancer	5.91e-06	8.69e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Capecitabine—breast cancer	5.91e-06	8.68e-05	CcSEcCtD
Tamoxifen—Fatigue—Capecitabine—breast cancer	5.9e-06	8.67e-05	CcSEcCtD
Tamoxifen—Pruritus—Paclitaxel—breast cancer	5.9e-06	8.67e-05	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—breast cancer	5.87e-06	8.63e-05	CcSEcCtD
Tamoxifen—Pain—Capecitabine—breast cancer	5.85e-06	8.6e-05	CcSEcCtD
Tamoxifen—Constipation—Capecitabine—breast cancer	5.85e-06	8.6e-05	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—breast cancer	5.84e-06	8.58e-05	CcSEcCtD
Tamoxifen—Nausea—Fluorouracil—breast cancer	5.82e-06	8.55e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Docetaxel—breast cancer	5.78e-06	8.49e-05	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—breast cancer	5.77e-06	8.48e-05	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—breast cancer	5.76e-06	8.47e-05	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—breast cancer	5.72e-06	8.41e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Paclitaxel—breast cancer	5.7e-06	8.39e-05	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—breast cancer	5.65e-06	8.3e-05	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—breast cancer	5.61e-06	8.25e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Capecitabine—breast cancer	5.59e-06	8.22e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Docetaxel—breast cancer	5.59e-06	8.21e-05	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—breast cancer	5.59e-06	8.21e-05	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—breast cancer	5.55e-06	8.15e-05	CcSEcCtD
Tamoxifen—Dizziness—Paclitaxel—breast cancer	5.51e-06	8.1e-05	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—breast cancer	5.49e-06	8.06e-05	CcSEcCtD
Tamoxifen—Cough—Methotrexate—breast cancer	5.45e-06	8.01e-05	CcSEcCtD
Tamoxifen—Urticaria—Capecitabine—breast cancer	5.44e-06	7.99e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Capecitabine—breast cancer	5.41e-06	7.95e-05	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—breast cancer	5.4e-06	7.94e-05	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—breast cancer	5.4e-06	7.93e-05	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—breast cancer	5.31e-06	7.81e-05	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—breast cancer	5.31e-06	7.81e-05	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—breast cancer	5.31e-06	7.81e-05	CcSEcCtD
Tamoxifen—Vomiting—Paclitaxel—breast cancer	5.3e-06	7.79e-05	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—breast cancer	5.29e-06	7.78e-05	CcSEcCtD
Tamoxifen—Rash—Paclitaxel—breast cancer	5.26e-06	7.73e-05	CcSEcCtD
Tamoxifen—Dermatitis—Paclitaxel—breast cancer	5.25e-06	7.72e-05	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—breast cancer	5.25e-06	7.72e-05	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—breast cancer	5.23e-06	7.68e-05	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—breast cancer	5.23e-06	7.68e-05	CcSEcCtD
Tamoxifen—Headache—Paclitaxel—breast cancer	5.22e-06	7.68e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Docetaxel—breast cancer	5.21e-06	7.65e-05	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—breast cancer	5.2e-06	7.64e-05	CcSEcCtD
Tamoxifen—Cough—Epirubicin—breast cancer	5.1e-06	7.49e-05	CcSEcCtD
Tamoxifen—Asthenia—Docetaxel—breast cancer	5.07e-06	7.45e-05	CcSEcCtD
Tamoxifen—Infection—Methotrexate—breast cancer	5.06e-06	7.44e-05	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—breast cancer	5.04e-06	7.41e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Capecitabine—breast cancer	5.04e-06	7.41e-05	CcSEcCtD
Tamoxifen—Pruritus—Docetaxel—breast cancer	5e-06	7.35e-05	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—breast cancer	4.99e-06	7.34e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—breast cancer	4.99e-06	7.33e-05	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—breast cancer	4.97e-06	7.31e-05	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—breast cancer	4.97e-06	7.31e-05	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—breast cancer	4.97e-06	7.31e-05	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—breast cancer	4.95e-06	7.28e-05	CcSEcCtD
Tamoxifen—Nausea—Paclitaxel—breast cancer	4.95e-06	7.28e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—breast cancer	4.92e-06	7.24e-05	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—breast cancer	4.91e-06	7.22e-05	CcSEcCtD
Tamoxifen—Asthenia—Capecitabine—breast cancer	4.91e-06	7.22e-05	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—breast cancer	4.86e-06	7.15e-05	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—breast cancer	4.85e-06	7.14e-05	CcSEcCtD
Tamoxifen—Pruritus—Capecitabine—breast cancer	4.84e-06	7.12e-05	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—breast cancer	4.84e-06	7.11e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Docetaxel—breast cancer	4.83e-06	7.11e-05	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—breast cancer	4.77e-06	7.01e-05	CcSEcCtD
Tamoxifen—Infection—Epirubicin—breast cancer	4.74e-06	6.96e-05	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—breast cancer	4.72e-06	6.93e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Capecitabine—breast cancer	4.68e-06	6.88e-05	CcSEcCtD
Tamoxifen—Dizziness—Docetaxel—breast cancer	4.67e-06	6.87e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—breast cancer	4.67e-06	6.86e-05	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—breast cancer	4.67e-06	6.86e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—breast cancer	4.64e-06	6.82e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—breast cancer	4.61e-06	6.77e-05	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—breast cancer	4.61e-06	6.77e-05	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—breast cancer	4.6e-06	6.76e-05	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—breast cancer	4.6e-06	6.76e-05	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—breast cancer	4.6e-06	6.76e-05	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—breast cancer	4.58e-06	6.74e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—breast cancer	4.57e-06	6.72e-05	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—breast cancer	4.55e-06	6.68e-05	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—breast cancer	4.54e-06	6.68e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—breast cancer	4.54e-06	6.67e-05	CcSEcCtD
Tamoxifen—Dizziness—Capecitabine—breast cancer	4.52e-06	6.65e-05	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—breast cancer	4.5e-06	6.61e-05	CcSEcCtD
Tamoxifen—Vomiting—Docetaxel—breast cancer	4.49e-06	6.6e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—breast cancer	4.48e-06	6.59e-05	CcSEcCtD
Tamoxifen—Rash—Docetaxel—breast cancer	4.46e-06	6.55e-05	CcSEcCtD
Tamoxifen—Dermatitis—Docetaxel—breast cancer	4.45e-06	6.54e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—breast cancer	4.43e-06	6.51e-05	CcSEcCtD
Tamoxifen—Headache—Docetaxel—breast cancer	4.43e-06	6.51e-05	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—breast cancer	4.41e-06	6.48e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—breast cancer	4.4e-06	6.46e-05	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—breast cancer	4.39e-06	6.45e-05	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—breast cancer	4.38e-06	6.44e-05	CcSEcCtD
Tamoxifen—Pain—Methotrexate—breast cancer	4.36e-06	6.4e-05	CcSEcCtD
Tamoxifen—Vomiting—Capecitabine—breast cancer	4.35e-06	6.39e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—breast cancer	4.34e-06	6.38e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—breast cancer	4.32e-06	6.35e-05	CcSEcCtD
Tamoxifen—Rash—Capecitabine—breast cancer	4.31e-06	6.34e-05	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—breast cancer	4.31e-06	6.34e-05	CcSEcCtD
Tamoxifen—Dermatitis—Capecitabine—breast cancer	4.31e-06	6.34e-05	CcSEcCtD
Tamoxifen—Headache—Capecitabine—breast cancer	4.29e-06	6.3e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—breast cancer	4.28e-06	6.29e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—breast cancer	4.26e-06	6.27e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—breast cancer	4.25e-06	6.25e-05	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—breast cancer	4.2e-06	6.18e-05	CcSEcCtD
Tamoxifen—Nausea—Docetaxel—breast cancer	4.2e-06	6.17e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—breast cancer	4.2e-06	6.17e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—breast cancer	4.16e-06	6.12e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—breast cancer	4.14e-06	6.09e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—breast cancer	4.11e-06	6.05e-05	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—breast cancer	4.11e-06	6.04e-05	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—breast cancer	4.08e-06	5.99e-05	CcSEcCtD
Tamoxifen—Pain—Epirubicin—breast cancer	4.08e-06	5.99e-05	CcSEcCtD
Tamoxifen—Nausea—Capecitabine—breast cancer	4.06e-06	5.97e-05	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—breast cancer	4.05e-06	5.95e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—breast cancer	4.03e-06	5.92e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.02e-06	5.91e-05	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—breast cancer	3.99e-06	5.86e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—breast cancer	3.96e-06	5.82e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—breast cancer	3.93e-06	5.78e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—breast cancer	3.9e-06	5.73e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—breast cancer	3.88e-06	5.71e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—breast cancer	3.83e-06	5.64e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—breast cancer	3.81e-06	5.6e-05	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—breast cancer	3.8e-06	5.59e-05	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—breast cancer	3.79e-06	5.57e-05	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—breast cancer	3.77e-06	5.54e-05	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—breast cancer	3.77e-06	5.54e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—breast cancer	3.77e-06	5.54e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—breast cancer	3.75e-06	5.52e-05	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—breast cancer	3.65e-06	5.37e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—breast cancer	3.61e-06	5.3e-05	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—breast cancer	3.6e-06	5.3e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—breast cancer	3.51e-06	5.16e-05	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—breast cancer	3.5e-06	5.15e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—breast cancer	3.49e-06	5.12e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—breast cancer	3.48e-06	5.12e-05	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—breast cancer	3.42e-06	5.03e-05	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—breast cancer	3.37e-06	4.96e-05	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—breast cancer	3.37e-06	4.95e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—breast cancer	3.26e-06	4.79e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—breast cancer	3.25e-06	4.78e-05	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—breast cancer	3.24e-06	4.76e-05	CcSEcCtD
Tamoxifen—Rash—Methotrexate—breast cancer	3.21e-06	4.72e-05	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—breast cancer	3.21e-06	4.72e-05	CcSEcCtD
Tamoxifen—Headache—Methotrexate—breast cancer	3.19e-06	4.69e-05	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—breast cancer	3.16e-06	4.65e-05	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—breast cancer	3.15e-06	4.63e-05	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—breast cancer	3.12e-06	4.59e-05	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—breast cancer	3.03e-06	4.45e-05	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—breast cancer	3.03e-06	4.45e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—breast cancer	3.02e-06	4.44e-05	CcSEcCtD
Tamoxifen—Rash—Epirubicin—breast cancer	3.01e-06	4.42e-05	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—breast cancer	3e-06	4.41e-05	CcSEcCtD
Tamoxifen—Headache—Epirubicin—breast cancer	2.99e-06	4.39e-05	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—breast cancer	2.92e-06	4.29e-05	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—breast cancer	2.83e-06	4.16e-05	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—breast cancer	2.8e-06	4.12e-05	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—breast cancer	2.78e-06	4.09e-05	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—breast cancer	2.78e-06	4.08e-05	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—breast cancer	2.76e-06	4.06e-05	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—breast cancer	2.62e-06	3.85e-05	CcSEcCtD
Tamoxifen—CYP1A2—Metabolism—CYP3A4—breast cancer	3.21e-07	7.1e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—breast cancer	3.21e-07	7.1e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TYMS—breast cancer	3.2e-07	7.08e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—breast cancer	3.2e-07	7.07e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.19e-07	7.07e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ITPR1—breast cancer	3.19e-07	7.06e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—breast cancer	3.18e-07	7.04e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—breast cancer	3.17e-07	7.01e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ITPR1—breast cancer	3.16e-07	7e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLA2G4A—breast cancer	3.16e-07	6.99e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NCOR1—breast cancer	3.16e-07	6.99e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—breast cancer	3.16e-07	6.99e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—breast cancer	3.16e-07	6.99e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1B1—breast cancer	3.16e-07	6.98e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HPGDS—breast cancer	3.15e-07	6.98e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—breast cancer	3.14e-07	6.95e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HBA1—breast cancer	3.13e-07	6.93e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—breast cancer	3.12e-07	6.9e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—breast cancer	3.11e-07	6.88e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX1—breast cancer	3.1e-07	6.86e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.09e-07	6.85e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.08e-07	6.82e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—breast cancer	3.08e-07	6.81e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A1—breast cancer	3.07e-07	6.79e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—breast cancer	3.07e-07	6.79e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—breast cancer	3.07e-07	6.79e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ACHE—breast cancer	3.06e-07	6.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—breast cancer	3.06e-07	6.77e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ERCC2—breast cancer	3.04e-07	6.74e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—breast cancer	3.04e-07	6.73e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX1—breast cancer	3.03e-07	6.7e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—breast cancer	3.02e-07	6.69e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TYMS—breast cancer	3.01e-07	6.67e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NCOA1—breast cancer	3.01e-07	6.66e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A1—breast cancer	3e-07	6.63e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—breast cancer	2.99e-07	6.63e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TYMS—breast cancer	2.99e-07	6.61e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.98e-07	6.59e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—breast cancer	2.98e-07	6.59e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NCOR1—breast cancer	2.98e-07	6.59e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ERCC2—breast cancer	2.97e-07	6.58e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—STK11—breast cancer	2.97e-07	6.57e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP19A1—breast cancer	2.97e-07	6.57e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAV1—breast cancer	2.96e-07	6.54e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.95e-07	6.53e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NCOR1—breast cancer	2.95e-07	6.53e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—breast cancer	2.95e-07	6.53e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—breast cancer	2.94e-07	6.5e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—breast cancer	2.92e-07	6.46e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RAF1—breast cancer	2.91e-07	6.44e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RELA—breast cancer	2.9e-07	6.41e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP17A1—breast cancer	2.89e-07	6.4e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—breast cancer	2.88e-07	6.37e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—breast cancer	2.87e-07	6.36e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO1—breast cancer	2.86e-07	6.34e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS1—breast cancer	2.86e-07	6.34e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—breast cancer	2.86e-07	6.33e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX1—breast cancer	2.85e-07	6.31e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—breast cancer	2.85e-07	6.3e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—breast cancer	2.84e-07	6.29e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—breast cancer	2.84e-07	6.29e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX1—breast cancer	2.83e-07	6.26e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.83e-07	6.25e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A1—breast cancer	2.82e-07	6.25e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2D6—breast cancer	2.81e-07	6.22e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ERCC2—breast cancer	2.8e-07	6.2e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A1—breast cancer	2.8e-07	6.19e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—breast cancer	2.8e-07	6.19e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—breast cancer	2.79e-07	6.18e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.79e-07	6.16e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ERCC2—breast cancer	2.78e-07	6.14e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—breast cancer	2.76e-07	6.11e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—COMT—breast cancer	2.76e-07	6.11e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOA2—breast cancer	2.76e-07	6.1e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—breast cancer	2.75e-07	6.08e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—breast cancer	2.74e-07	6.06e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—breast cancer	2.73e-07	6.05e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—breast cancer	2.73e-07	6.04e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—breast cancer	2.71e-07	5.99e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—breast cancer	2.7e-07	5.99e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ITPR1—breast cancer	2.7e-07	5.98e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—breast cancer	2.7e-07	5.97e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—breast cancer	2.69e-07	5.96e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FASN—breast cancer	2.67e-07	5.92e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1B—breast cancer	2.67e-07	5.9e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—breast cancer	2.66e-07	5.89e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—breast cancer	2.64e-07	5.85e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAV1—breast cancer	2.64e-07	5.84e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—breast cancer	2.63e-07	5.83e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—breast cancer	2.63e-07	5.82e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—breast cancer	2.61e-07	5.78e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—breast cancer	2.61e-07	5.78e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—breast cancer	2.61e-07	5.78e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—breast cancer	2.61e-07	5.77e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—breast cancer	2.6e-07	5.75e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—breast cancer	2.59e-07	5.73e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—breast cancer	2.58e-07	5.72e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—breast cancer	2.58e-07	5.71e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAV1—breast cancer	2.58e-07	5.7e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TYMS—breast cancer	2.55e-07	5.65e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—breast cancer	2.55e-07	5.64e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—breast cancer	2.54e-07	5.63e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A1—breast cancer	2.54e-07	5.62e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NQO1—breast cancer	2.54e-07	5.62e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—breast cancer	2.54e-07	5.62e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—breast cancer	2.52e-07	5.58e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NCOR1—breast cancer	2.52e-07	5.58e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.52e-07	5.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.52e-07	5.58e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—breast cancer	2.52e-07	5.58e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—breast cancer	2.51e-07	5.55e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—breast cancer	2.47e-07	5.47e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—breast cancer	2.46e-07	5.45e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—breast cancer	2.46e-07	5.43e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—breast cancer	2.44e-07	5.4e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—breast cancer	2.44e-07	5.4e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1B1—breast cancer	2.44e-07	5.39e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAV1—breast cancer	2.43e-07	5.37e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX1—breast cancer	2.42e-07	5.35e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—breast cancer	2.42e-07	5.35e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAV1—breast cancer	2.41e-07	5.33e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—breast cancer	2.4e-07	5.32e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK8—breast cancer	2.4e-07	5.32e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1A1—breast cancer	2.39e-07	5.29e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.39e-07	5.29e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—breast cancer	2.39e-07	5.28e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—breast cancer	2.38e-07	5.27e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ERCC2—breast cancer	2.37e-07	5.25e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—breast cancer	2.37e-07	5.24e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—breast cancer	2.37e-07	5.24e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—breast cancer	2.36e-07	5.23e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—breast cancer	2.35e-07	5.19e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—breast cancer	2.34e-07	5.17e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOA1—breast cancer	2.32e-07	5.14e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—breast cancer	2.31e-07	5.12e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.3e-07	5.09e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP19A1—breast cancer	2.29e-07	5.07e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—STK11—breast cancer	2.29e-07	5.07e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—breast cancer	2.28e-07	5.04e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—breast cancer	2.25e-07	4.98e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—breast cancer	2.24e-07	4.95e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—breast cancer	2.23e-07	4.94e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—breast cancer	2.23e-07	4.93e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—breast cancer	2.23e-07	4.93e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—breast cancer	2.22e-07	4.91e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—breast cancer	2.21e-07	4.89e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—breast cancer	2.2e-07	4.86e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—breast cancer	2.19e-07	4.85e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—breast cancer	2.18e-07	4.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—COMT—breast cancer	2.13e-07	4.71e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—breast cancer	2.12e-07	4.69e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—breast cancer	2.11e-07	4.68e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—breast cancer	2.11e-07	4.66e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK3—breast cancer	2.1e-07	4.64e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—breast cancer	2.09e-07	4.62e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—breast cancer	2.09e-07	4.62e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ITPR1—breast cancer	2.08e-07	4.61e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—breast cancer	2.06e-07	4.57e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—breast cancer	2.06e-07	4.57e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—breast cancer	2.06e-07	4.57e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—breast cancer	2.06e-07	4.56e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAV1—breast cancer	2.06e-07	4.55e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—breast cancer	2.05e-07	4.53e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—breast cancer	2.04e-07	4.52e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—breast cancer	2.04e-07	4.51e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—breast cancer	2.04e-07	4.51e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—breast cancer	2.03e-07	4.49e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—breast cancer	2.01e-07	4.45e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—breast cancer	2.01e-07	4.44e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—breast cancer	2e-07	4.42e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—breast cancer	2e-07	4.42e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TYMS—breast cancer	1.97e-07	4.36e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.96e-07	4.35e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—breast cancer	1.95e-07	4.31e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.95e-07	4.31e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—breast cancer	1.95e-07	4.31e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOR1—breast cancer	1.95e-07	4.31e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—breast cancer	1.95e-07	4.31e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—breast cancer	1.94e-07	4.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—breast cancer	1.93e-07	4.27e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—breast cancer	1.92e-07	4.25e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—breast cancer	1.9e-07	4.21e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—breast cancer	1.89e-07	4.18e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—breast cancer	1.89e-07	4.17e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—breast cancer	1.87e-07	4.15e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX1—breast cancer	1.86e-07	4.13e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A1—breast cancer	1.85e-07	4.09e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—breast cancer	1.84e-07	4.08e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—breast cancer	1.84e-07	4.08e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—breast cancer	1.84e-07	4.06e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ERCC2—breast cancer	1.83e-07	4.05e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—breast cancer	1.83e-07	4.04e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—breast cancer	1.82e-07	4.03e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—breast cancer	1.82e-07	4.03e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—breast cancer	1.8e-07	3.98e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—breast cancer	1.78e-07	3.95e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—breast cancer	1.78e-07	3.94e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—breast cancer	1.73e-07	3.83e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—breast cancer	1.72e-07	3.81e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—breast cancer	1.69e-07	3.75e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—breast cancer	1.68e-07	3.72e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—breast cancer	1.68e-07	3.72e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—breast cancer	1.68e-07	3.71e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—breast cancer	1.66e-07	3.68e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—breast cancer	1.66e-07	3.67e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—breast cancer	1.65e-07	3.64e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—breast cancer	1.64e-07	3.63e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—breast cancer	1.63e-07	3.6e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—breast cancer	1.6e-07	3.55e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—breast cancer	1.59e-07	3.52e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAV1—breast cancer	1.59e-07	3.51e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—breast cancer	1.56e-07	3.44e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—breast cancer	1.55e-07	3.44e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—breast cancer	1.53e-07	3.4e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—breast cancer	1.5e-07	3.33e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—breast cancer	1.49e-07	3.29e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—breast cancer	1.46e-07	3.24e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—breast cancer	1.46e-07	3.22e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—breast cancer	1.45e-07	3.22e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—breast cancer	1.45e-07	3.21e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—breast cancer	1.45e-07	3.2e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—breast cancer	1.44e-07	3.18e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—breast cancer	1.42e-07	3.15e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—breast cancer	1.42e-07	3.13e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—breast cancer	1.37e-07	3.04e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—breast cancer	1.27e-07	2.81e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—breast cancer	1.26e-07	2.78e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—breast cancer	1.25e-07	2.78e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—breast cancer	1.24e-07	2.75e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—breast cancer	1.21e-07	2.69e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—breast cancer	1.2e-07	2.66e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—breast cancer	1.19e-07	2.63e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—breast cancer	1.19e-07	2.63e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—breast cancer	1.12e-07	2.49e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—breast cancer	1.12e-07	2.48e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—breast cancer	1.11e-07	2.45e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—breast cancer	1.1e-07	2.43e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—breast cancer	1.1e-07	2.43e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—breast cancer	1.03e-07	2.29e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—breast cancer	1.03e-07	2.27e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—breast cancer	1.02e-07	2.27e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—breast cancer	9.57e-08	2.12e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—breast cancer	9.17e-08	2.03e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—breast cancer	8.95e-08	1.98e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—breast cancer	8.75e-08	1.94e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—breast cancer	8.44e-08	1.87e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—breast cancer	8.37e-08	1.85e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—breast cancer	7.15e-08	1.58e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—breast cancer	6.75e-08	1.49e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—breast cancer	5.52e-08	1.22e-06	CbGpPWpGaD
